Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T Simon
SAT0177 Safety Events Are Similar With Abatacept vs Placebo Treatment in Ra: Results From Integrated Data Analysis From Nine Clinical Trials
Related publications
Are Results From Clinical Trials Reliable?
The Lancet Oncology
Oncology
060 Integrated Safety of Ixekizumab in Patients With Moderate-To-Severe Psoriasis: Results From a Pooled Analysis of 7 Clinical Trials
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of Up to 8 Years of Treatment From the Abatacept Clinical Trial Program
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Safety and Tolerability of Duloxetine in the Treatment of Patients With Fibromyalgia: Pooled Analysis of Data From Five Clinical Trials
Clinical Rheumatology
Medicine
Rheumatology
Factors Predictive of Treatment-Emergent Adverse Events of Prucalopride: An Integrated Analysis of Four Randomized, Double-Blind, Placebo-Controlled Trials
Gut and Liver
Hepatology
Gastroenterology
Sharing Individual Patient Data From Clinical Trials
New England Journal of Medicine
Medicine
FRI0213 Comparative Effectiveness of Abatacept, Rituximab, Tocilizumab and Anti-TNF Biological Dmards in Ra: Results From the Nationwide Swedish Register
Arthritis Prevention in the Pre-Clinical Phase of RA With Abatacept (The APIPPRA Study): A Multi-Centre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Clinical Trial Protocol
Trials
Medicine
Pharmacology
Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies
Headache
Neurology